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Abstract
Background—The number needed to treat ratio is an effective method for measuring accuracy
in melanoma detection. Dermoscopy reduces the number of false positives and subsequently
unnecessary excisions. In vivo confocal microscopy is a non-invasive technique which allows the
examination of the skin with cellular resolution.
Objectives—To assess the impact of RCM analysis on the number of equivocal lesions, assumed
to be melanocytic, excised for every melanoma.
Methods—Consecutive patients (n=343) presenting with doubtful lesions, were considered for
enrolment. The lesions were analysed by dermoscopy and RCM and histopathological assessment
was considered the reference standard. The main outcome was the number needed to treat,
calculated as the proportion of equivocal lesions, excised for every melanoma.
Results—Dermoscopy alone obtained a hypothetical NNT of 3.73, the combination of
dermoscopy and RCM identified 264 equivocal lesions that qualified for excision, 92 of which
were confirmed to be a melanoma; resulting in a NNT of 2.87; whereas the analysis of RCM
images classified as melanoma 103 lesions with a consequent NNT of 1.12; the difference in the
reduction of this ratio was statistically significant (p< 0.0001) between the three groups. There
was no significant improvement in sensitivity when comparing the combination of dermoscopy
and RCM and RCM alone (94.56% vs. 97.82%; p = 0.043). However, the differences between
specificities were statistically significant (p <0.000001), favouring RCM alone.
Conclusion—The addition of RCM analysis to dermoscopy reduces unnecessary excisions with
a high diagnostic accuracy and could be a means for reducing the economic impact associated
with the management of skin cancer.
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INTRODUCTION
Concerns about the increasing incidence of melanoma in white populations have focused on
the well documented association between early excision and reduction of mortality1–3. In
line with this effort, dermoscopy has been shown to improve the diagnostic accuracy for
melanoma in comparison with the unaided-eye examination in four meta-analyses
performed on studies conducted in both clinical and experimental settings 4–7. One effective
method for measuring the accuracy in melanoma detection is the number needed to treat
(NNT), calculated as the number of pigmented lesions excised to detect a melanoma8.
Although this value depends on the prevalence of the disease and varies according to
physician and lesion-related variables 8–10, it has been proposed to be an useful indicator of
the efficient use of healthcare resources11.
The addition of dermoscopy to melanoma screening has been associated with a reduction in
the false-positive detection rate and a subsequent decrease of unnecessary excisions,
showing a clinically relevant effect in terms of lesion management 12–20. The reported NNT
between non-dermoscopy users ranged from about 10 to 15 14,19 and dramatically improves
to at least 4 14,19 and as high as 2.4 for properly trained dermatologists with access to digital
dermoscopy 20.
In vivo reflectance mode confocal microscopy (RCM) is a non-invasive technique which
allows the examination of the epidermis and papillary dermis at cellular resolution. 21,22
Several studies have evaluated the diagnostic accuracy of RCM for equivocal melanocytic
lesions, concluding that the use of this novel technique provides a significant improvement
in melanoma detection 23–29, even in small, featureless or amelanotic melanoma.30–33
Our aim in this study was to assess the impact of RCM analysis on the number of
dermoscopically equivocal pigmented lesions excised for every melanoma, in a clinical
setting.
MATERIALS AND METHODS
Study Population
Consecutive patients presenting at the Melanoma Unit of Hospital Clinic in Barcelona with
dermoscopically equivocal pigmented lesions, assumed to be melanocytic, were considered
for enrolment.
Data collection
The previously published dermoscopic criteria for diagnosing melanoma and the criteria for
changes in digital follow up 34 were used to establish the eligibility of lesions 35–37. Data
regarding age, gender, anatomic location, melanoma risk factors and dermoscopic diagnosis
was collected before the RCM examination and histopathological analyses were performed.
Instruments and Procedures
All the lesions were imaged with a digital camera (Canon PowerShot G10, Canon, Tokyo,
Japan) and a high resolution dermatoscope (DermLite Photo, 3GEN, LLC Dana Point, CA,
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USA). Before biopsy, in vivo confocal microscopy was performed with a commercially
available reflectance confocal microscope (Vivascope 1500; Lucid Inc., Henrietta, NY,
USA), which uses a near-infrared laser at 830 nm wavelength with a maximum power of
35mW. The image acquisition method was published elsewhere 22 and we established a
protocol including serial optical sections obtained at the stratum corneum, stratum
granulosum and/or stratum spinosum, dermoepidermal junction (DEJ) and papillary dermis.
The previously described specific RCM criteria for melanoma including four diagnostic
features were followed to assess all the images39. The presence of two protective criteria in
the basal layer with a score of −1 were considered: 1) edged papillae and 2) presence of
typical cells in the basal layer; and the presence of 2 risk criteria with a score of 1 were also
considered: 1) presence of round pagetoid cells in upper layers of the epidermis and
presence of the nucleated cells found within the dermal papillae. A threshold score greater
than −1 was used to obtain a diagnosis of melanoma.
The dermoscopy and RCM diagnosis were made prospectively and therefore, blinded to
pathological outcome, but not to clinical information such as age and anatomic location. All
the images were interpreted independently by one of the three dermatologists with expertise
in RCM (C.C; S.P; J.M). Histopathological assessment was considered the reference
standard for diagnosing melanoma40 and was performed by certified dermatopathologists,
blinded to the result of RCM examination, in order to avoid review bias 41.
Outcomes
The primary outcome was the NNT, calculated as the proportion of dermoscopically and
RCM equivocal pigmented lesions, assumed to be melanocytic, excised for every
melanoma. Secondary outcomes included sensitivity, specificity, positive predictive value
and negative predictive value of each technique for diagnosing melanoma. According to the
method used to decide the excision, the lesions were categorized into three groups. The first
group included the lesions intended for excision based on dermoscopy alone; the second
group contained the lesions for which dermoscopy and RCM were used to decide excision
and the third group was comprised of the lesions for excision based on the analysis of the
RCM images. All excised lesions considered to be a melanoma by means of dermoscopy or
RCM and confirmed by histopathology were defined as true positives (TP) whereas the true
negatives (TN) were the lesions assumed to be non melanoma and afterwards diagnosed as
non melanoma (by histopathology). False negatives (FN) included all the melanomas
excised with a diagnosis of non melanoma; and false positives (FP) were defined as lesions
with a preoperative diagnosis of melanoma not confirmed by histopathology. All the patients
with not excised lesions and those with excised lesions were scheduled for a strict follow up
including at least 2 visits within a year.
Statistical Analysis
Statistical analyses were performed using SPSS 16.0 (SPSS, Chicago, IL) software. The
NNT was calculated for all excised lesions and then adjusted for a range of clinical variables
(patient sex, age groups and anatomic site); if distributed differently they were included in
multivariate analysis using logistic regression model. In order to compare the two diagnostic
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tests for the paired sample of the study, a matched sample table was constructed and the raw
data in this table was divided according to the final diagnosis as “melanoma” and “non-
melanoma”. For these two groups, contingency tables were created, with the two
examination techniques being referenced against each other. Sensitivity, specificity, positive
and negative predictive values were estimated for each method and compared using Mac
Nemar test for proportions.
RESULTS
We prospectively assessed data from patients at the Melanoma Unit in Hospital Clinic of
Barcelona between 1st June 2011 and 30th May 2012. From a target population of 5520
patients, we found an estimated 1534 lesions to be eligible; 1191 lesions were scheduled for
digital follow-up or immediate surgical excision, leaving 343 lesions that qualified for this
study. Of these lesions, 264 were finally excised (Fig. 1). The reason why patients were
scheduled for digital follow up was the lack of a worrisome change in lesions already
included in the digital follow program. The demographic characteristics of the study
population, the melanoma characteristics, and the diagnosis of the non melanoma pathology
are presented in Table 1. Patients were scheduled to undergo RCM before histopathological
analysis, both of which were performed on the same day.
Following the use of dermoscopy, 343 of the lesions classified as equivocal would
eventually be excised. After the addition of RCM, 77 % (264 of 343) of lesions were judged
as suggestive of malignancy according to the criteria followed in the study, and therefore,
excised. The 79 lesions without criteria of malignancy upon RCM examination were
scheduled for clinical or digital follow up. The consequent reduction of 23 % (79 of 343) of
lesions selected for excisional biopsy following RCM was statistically significant compared
to the percentage selected by means of dermoscopy alone (p < 0.0001).
In table 2, the effect of RCM on the NNT melanoma is shown. In the first group dermoscopy
alone identified 343 equivocal pigmented lesions that qualified for excision, resulting in a
hypothetical NNT of 3.73, if all these 343 lesions would had been excised; this is illustrated
in Fig. 2, which shows a false positive of lentigo maligna, diagnosed by dermoscopy
presenting clear features of solar lentigo under RCM examination. The second group
contained the 264 lesions where excision was decided by both dermoscopy and RCM
criteria, the resulting NNT was 2.87. In the third group, the analysis of the RCM images
classified 103 lesions as melanoma, with a consequent hypothetical NNT of 1.12 if only the
lesions selected by this method had been excised. The reduction in this ratio was statistically
significant between the two methods of assessment (p< 0.0001). Based on the diagnosis
made by the expert using dermoscopy, a total of six false negatives were found; all of them
were diagnosed by pathology as in situ melanomas. Two false negatives were encountered
for RCM, in both cases the lesions were considered as atypical nevi in the prospective
evaluation, and after being excised, both of them were classified as in situ melanomas. Table
3 presents the statistical measures calculated for each method.
As shown in Table 4, when comparing dermoscopy diagnosis and RCM diagnosis in
preselected lesions by dermoscopy, against histopathology, the reference standard, there was
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no significant improvement in sensitivity (94.56% vs 97.82%; p = 0.043) for the diagnosis
of melanoma. However, the differences between specificities for the two methods were
statistically significant (p <0.000001). After analysing the Breslow thickness and the
pathology of melanoma type, neither the sensitivity nor the specificity varied according to
each examination technique. After one year of follow up, all the patients included completed
at least 2 visits and no additional melanoma was diagnosed.
DISCUSSION
The major outcome of our study is the significant reduction on the NNT as a result of the
addition of RCM to dermoscopy in real clinical practice. Since the performance of the
examination technique has a direct effect on the NNT14,18,19, this low ratio (1.12) could be
explained by the high diagnostic accuracy of RCM in melanoma detection. The hypothetical
NNT we have calculated for dermoscopy (3.73) is in line with those of previous publications
evaluating NNT for dermoscopy and digital dermoscopy 12–20. Although several studies on
the diagnostic accuracy of RCM have been published, not many evaluated the impact of
RCM in a clinical setting. Only two studies compared the performance of RCM with
dermoscopy 23,29 and only the latter assessed the additive value of RCM in the management
of melanocytic skin lesions29. The former study prospectively evaluated the diagnostic
accuracy of RCM and dermoscopy examining melanocytic lesions, and did not find any
significant difference between the sensitivities and specificities of the two techniques. In
contrast to these results, we found higher specificity when using RCM, but these results
could be influenced by the design of the study. The fact that 79 lesions following RCM
examination were not excised, impaired our specificity and sensitivity analysis, but our
study design prioritized the real impact of RCM in the clinical arena. The two melanomas
misdiagnosed by the expert evaluating RCM were in situ melanomas classified
prospectively as nevi with atypical RCM features. When we review these two lesions
retrospectively applying the RCM second step score for melanoma, the score was 0, and
melanoma should be suspected (with this method only negative values were not associated
with melanoma). The first lesion was an achromic papule showing arborizing vessels under
dermoscopy and the second was a melanocytic lesion with globular pattern (Fig. 3).
Interestingly, both cases were correctly suspected by clinical and dermoscopical judgement.
The first case was a patient diagnosed with Xeroderma Pigmentosum who had seven
previous melanomas, and the second patient presented a lesion suspected to be melanoma by
means of observed changes in sequential dermoscopy imaging. Both techniques together did
not miss any melanoma, and all the lesions classified as benign by RCM were scheduled for
clinical or digital follow up. One year after the end of the study, no additional melanoma
was diagnosed. The design of our study did not allow us to clarify whether RCM alone
would have reduced the NNT as low as it did, as dermoscopy was the first step used to select
the lesions to be subjected to RCM examination. We believe that the role of RCM is not to
replace but to complement dermoscopy.
There is one study 29 published using a set of images and simulating the conditions of a
clinical setting, ours are the first data evaluating the impact of RCM on the NNT ratio in a
clinical setting. In conclusion, the use of RCM in lesions preselected by dermoscopy or
digital follow-up reduces unnecessary excisions with a high diagnostic accuracy and could
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be a means for reducing the economic impact associated with the management of skin
cancer by reducing the excision of benign lesions.
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What’s already known about this topic?
Dermoscopy enhances the diagnostic accuracy for melanoma and dramatically decreases
the NNT ratio when used by properly trained dermatologists. RCM is a novel technique
that provides a significant improvement in melanoma detection.
What does this study add?
The addition of RCM to dermoscopy has a significant impact on the number of
dermoscopically equivocal pigmented lesions excised for every melanoma, reducing the
excision of benign lesions.
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Figure 1.
Flow diagram illustrating the design of the study and main outcomes. n = number of lesions
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Figure 2.
(a) Clinical picture and (b) dermoscopy showing a large asymmetric lesion with atypical
pseudonetwork pattern, perifollicular pigmentation (white arrow) and some grey dots (black
arrow). (c) RCM mosaic 1000×1000 μm showing a preserved honeycomb pattern in
epidermis (*) without involvement of follicular openings (white arrows). (d) Cord-like
structures (black arrows) in a cerebriform distribution without atypical cells, very suggestive
of solar lentigo under RCM.
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Figure 3.
(a) Dermoscopy showing irregular globular pattern (b) RCM mosaic 1000×1000 μm
showing a preserved honeycomb pattern in epidermis (*). (c) RCM mosaic at
dermoepidermal junction showing irregular nests (*), with irregular edged papillae (blue
arrows), junctional thickenings (▲) and some atypical hyperreflective cells within the
dermal papillae (white arrows). (d) Histopathology (haematoxylin and eosin 20X) showing
atypical cells (black arrow) and nests (white arrow) from a in situ melanoma.
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Table 1
Demographic characteristics
Total
Sex
 Male 136
 Female 128
Age, and Median 54,5 (31–78)
Anatomic location
 Head and neck 73
 Trunk 135
 Limbs 49
 Acral 7
Melanoma Patients: 92
Breslow thickness median (IQ 25–75) mm 0.5 (0–1.3)
 < 1mm 86
 ≥ 1mm 6
Phototype
 I–II 42
 III–V 50
CDKN2A Mutation
 Carriers 4
 Wild Type 20
 Test not performed 68
Non melanoma Patients: 172
 Nevi 107
 BCC 12
 Others* 53
*
Includes seborrheic keratoses, pigmented actinic keratoses.
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Table 2
NNT according to the method used
Lesions intended for excision NNT
Dermoscopy 343 3.73
Dermoscopy & RCM 264 2.87
RCM 103 1.12
Excised lesions (n=264) Confirmed Melanoma by Histopathology (n=92)
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Table 3
Sensitivity, specificity, positive predictive value and negative predictive value depending on the method used
Dermoscopy n=264 CI 95% RCM n=264 CI 95%
Sensitivity % 94.56 (87.19 – 97.98) 97.82 (91.62 – 99.62)
Specificity % 26.74 (87.19 – 97.98) 92.44 (87.15 – 95.74)
Positive Predictive Value 40.84 (34.23 – 47.78) 87.37 (79.03 – 92.84)
Negative Predictive Value 90.19 (77.81 – 96.33) 98.75 (95.11 – 99.78)
n = excised lesions
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